满怀信心地推进药物发现

我们庞大的产品目录可提供生物序列、生物活性数据等重要信息，助您对候选药物进行优先排序。
了解有关药物发现的更多信息

CAS and Cleveland Clinic collaborate to accelerate brain health and Alzheimer’s research

Leading organizations unite data, advanced AI, and quantum computing capabilities to progress discovery to improve lives.
Learn more

Explore the new CAS BioFinder Discovery Platform

Move your drug discovery program through each phase quickly with access to life sciences data and a new solution.
Learn more

CAS SciFinder 助您加快创新速度

利用世界上最值得信赖的科学知识来源，加快探索之旅。
探索 CAS SciFinder

从科学文献中挖掘关键的生物材料趋势

西湖大学专注于尖端科学研究，寻求与一家在科学知识和先进数据分析能力方面具有丰富经验的机构合作。

阅读案例研究
Left arrow
Right arrow
Two hexagons connected by a yellow intersect
CAS 数据

标引科学文献，赋能科学发现

高质量数据是当今数字化研发管线的命脉。我们的科学家每天都会标引、关联、分析全球科学出版物中披露的高价值数据，创建了涵盖 150 多年科学发现的 CAS 内容合集™。

CAS 数据是 CAS 所有解决方案的基石，可被授权用于机器学习或内部工作流程整合。通过 CAS 定制服务，我们的科学家还支持定制化数据标引项目。

发现更多

Latest from CAS Insights™

Biotechnology

New breakthroughs in siRNA therapeutics expand the drug pipeline

Advances in drug development are improving the pipeline of siRNA therapeutics.
|文章
阅读文章
Drug Discovery

The latest trends in drug discovery

Explore eight leading trends in drug discovery that are improving cancer treatment, identifying neurodegenerative conditions, and even preparing for a future pandemic
|文章
阅读文章
Consumer Goods

The PFAS landscape: Understanding regulations, applications, and alternatives

PFAS molecules have remarkable properties. However, increasing concerns about health impacts are driving new regulations and the search for alternatives.
|文章
阅读文章
查看所有 CAS 见解